9 First Eagle Investments Eagle Pharmaceuticals Trades
First Eagle Investments started to build up the position in Eagle Pharmaceuticals in Q3 2016 and continued to invest until Q1 2017. Since then they sold 661 Thousand shares. The investor completely sold their stake between Q2 2017 and Q4 2018.
Avg closing price
Price range
Sold -214 Thousand shares
Q4 2018
Avg closing price
$51.53
Price range
$36.72
-
$67.73
Sold 5.5% shares (-12.5 Thousand shares)
Q3 2018
Avg closing price
$75.81
Price range
$66.65
-
$83.86
Sold 54.8% shares (-275 Thousand shares)
Q2 2018
Avg closing price
$62.91
Price range
$51.25
-
$76.62
Sold 16.7% shares (-101 Thousand shares)
Q1 2018
Avg closing price
$58.15
Price range
$52.16
-
$66.86
Sold 7.7% shares (-50 Thousand shares)
Q3 2017
Avg closing price
$60.49
Price range
$46.62
-
$83.48
Sold 1.4% shares (-9.5 Thousand shares)
Q2 2017
Avg closing price
$81.78
Price range
$69.28
-
$96.85
Increased shares by 4.1% (+26.2 Thousand shares)
Q1 2017
Avg closing price
$74.35
Price range
$62.83
-
$84.92
Increased shares by 11.7% (+66.6 Thousand shares)
Q4 2016